Literature DB >> 21302019

Detection of HPV by in situ hybridization in thin-layer (ThinPrep) cervicovaginal samples.

Francesc Alameda1, Maria Luisa Mariñoso, Beatriz Bellosillo, Mercè Muset, Silvia Pairet, Imma Soler, Emilia Romero, Fernando Larrazabal, Ramon Carreras, Sergi Serrano.   

Abstract

We have studied an automated in situ hybridization (ISH) method as a possible alternative approach for detecting high-risk human papillomavirus (HPV) in monolayer (ThinPrep) cervico-vaginal samples, comparing the results with those obtained by polymerase chain reaction (PCR) using consensus primers and studying the relationship between the ISH staining pattern and the viral integration in HPV 16-positive cases. Eighty atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesion (LSIL) cases were used for our purposes. The patients were monitored through periodic cytologies. ISH with was performed with an automated Ventana System, analysis by PCR was performed with consensus primers and integration of HPV16 was performed by realtime PCR analyzing E2 and E6 genes. Additionally, 27 HSIL cases were also studied to observe the ISH staining patterns. HPV infection was detected by ISH in 21.7% of the ASCUS cases and 55.8% of the LSIL cases. Two distinct staining patterns were observed: multipunctated (MP) and diffuse (DI). In some cases, a mixed pattern (MP + DI) was observed and these cases were considered as MP. The MP pattern increased with the degree of lesion and seemed to have a prognostic value in ASCUS/LSIL cases. The lesion in MP pattern cases persisted throughout the entire study in 77% of cases, whereas in cases with a DI staining pattern, only 41% of them showed persistence of the lesion (p <0.001). No correlation was found between HPV integration and the ISH staining pattern. Given the lower sensitivity and negative predictive value of ISH and its incapacity to demonstrate the integration of high-risk HPV in ASCUS and LSIL cases using liquid-based cytology, we do not recommend this technique for the triage of ASCUS and LSIL cases.

Entities:  

Mesh:

Year:  2011        PMID: 21302019     DOI: 10.1007/s13277-011-0159-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  22 in total

Review 1.  Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix.

Authors:  W A A Tjalma; T R Van Waes; L E M Van den Eeden; J J P M Bogers
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2005-03-21       Impact factor: 5.237

2.  HPV testing in cervical cytology practice: it's all about choice.

Authors:  Mark H Stoler
Journal:  Acta Cytol       Date:  2005 Mar-Apr       Impact factor: 2.319

3.  In situ hybridization with biotinylated tyramide amplification: detection of human papillomavirus DNA in cervical neoplastic lesions.

Authors:  T Sano; T Hikino; Y Niwa; K Kashiwabara; T Oyama; T Fukuda; T Nakajima
Journal:  Mod Pathol       Date:  1998-01       Impact factor: 7.842

4.  Biotinyl-tyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical intraepithelial neoplasia.

Authors:  Mark F Evans; Sharon L Mount; Barbara G Beatty; Kumarasen Cooper
Journal:  Mod Pathol       Date:  2002-12       Impact factor: 7.842

5.  HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.

Authors:  Lester J Layfield; M Nasar Qureshi
Journal:  Diagn Cytopathol       Date:  2005-08       Impact factor: 1.582

6.  Analytic sensitivities of hybrid-capture, consensus and type-specific polymerase chain reactions for the detection of human papillomavirus type 16 DNA.

Authors:  S Cavuslu; C Mant; W G Starkey; J M Bible; C Biswas; B Kell; P Rice; J M Best; J Cason
Journal:  J Med Virol       Date:  1996-08       Impact factor: 2.327

7.  Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions.

Authors:  P Birner; B Bachtiary; B Dreier; M Schindl; E A Joura; G Breitenecker; G Oberhuber
Journal:  Mod Pathol       Date:  2001-07       Impact factor: 7.842

8.  HPV in situ hybridization: impact of different protocols on the detection of integrated HPV.

Authors:  Anton H N Hopman; Miriam A Kamps; Frank Smedts; Ernst-Jan M Speel; C Simon Herrington; Frans C S Ramaekers
Journal:  Int J Cancer       Date:  2005-06-20       Impact factor: 7.396

9.  Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.

Authors:  Ming Guo; Yun Gong; Michael Deavers; Elvio G Silva; Yee Jee Jan; David E Cogdell; Rajyalashmi Luthra; E Lin; Hung Cheng Lai; Wei Zhang; Nour Sneige
Journal:  J Clin Microbiol       Date:  2007-10-31       Impact factor: 5.948

10.  HPV in situ hybridization signal patterns as a marker for cervical intraepithelial neoplasia progression.

Authors:  Renata De Marchi Triglia; Konradin Metze; Luiz Carlos Zeferino; Liliana A Lucci De Angelo Andrade
Journal:  Gynecol Oncol       Date:  2008-11-12       Impact factor: 5.482

View more
  1 in total

1.  Hybrid Capture 2 is as effective as PCR testing for high-risk human papillomavirus in head and neck cancers.

Authors:  Jody E Hooper; Jessica F Hebert; Amy Schilling; Neil D Gross; Joshua S Schindler; James P Lagowski; Molly Kulesz-Martin; Christopher L Corless; Terry K Morgan
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.